Kody Technolab Secures Exclusive Worldwide Mandate for AI-Powered Medigo Healthcare Screening Robots
Kody Technolab Limited, a deep-tech robotics and AI company, has entered into a multi-year tripartite agreement with Falcon Tech Robotics LLC and Sccore AI Tech Diagnostic Limited. This strategic arrangement appoints Kody Technolab as the exclusive worldwide manufacturer of its Medigo range of AI-powered healthcare screening robots.The agreement spans a three-year term, providing structured commercial visibility for Kody Technolab through a binding minimum purchase framework across biannual commercial periods. Manufacturing and supply are scheduled to commence in the first half (H1) of fiscal year 2026-27.
Under the structure, Kody Technolab is designated as the exclusive global manufacturer. Falcon Tech Robotics LLC, Kody Technolab's UAE joint venture, will handle the exclusive global distribution and commercial coordination. Sccore AI Tech Diagnostic Limited, also based in the UAE, will be responsible for worldwide deployment and commercialization of the products across international markets.
Addressing Global Health Needs
This engagement positions Kody Technolab at the forefront of a rapidly growing market addressing significant unmet health needs globally. Industry research suggests that the global preventive healthcare market is projected to grow substantially from approximately USD 268.7 billion in 2023 to USD 585.6 billion by 2030.The importance of these autonomous screening solutions is underscored by reports indicating that an estimated 4.5 billion people, representing over half the world's population, lack full access to essential health services. The tripartite agreement provides a scalable solution within this critical context.
The Medigo Robot Range
The Medigo range comprises four AI-powered healthcare screening robots, each designed for clinical-grade preventive screening that can be completed in minutes without requiring specialized medical staff. These devices are engineered to screen for a broad spectrum of conditions including metabolic, cardiovascular, infectious, sensory and mental health categories. Upon screening, the units generate a consolidated report in the patient's preferred language and feed anonymized data into institutional or government health dashboards.The Medigo range is detailed as follows:
| Robot Model | Primary Function / Target Area | Ideal Deployment Locations |
|---|---|---|
| Medigo Static | Stationary, autonomous health screening | Primary health centres, corporate campuses, public institutions |
| Medigo Kids | Paediatric screening for children's health check-ups | Schools, anganwadis, paediatric clinics |
| Medigo Women | Gender-specific preventive checkups | Maternal, reproductive and general wellness screening |
| Medigo Mobile | Moving 'health screening ATM' | Transit hubs, rural outreach routes, high-footfall public spaces |
Strategic Significance
The agreement reinforces Kody Technolab's strategic presence in the UAE and other international markets. The partnership combines Kody Technolab's engineering platform with Falcon's regional reach and Sccore's deployment capabilities.Manav Subhashchandra Patel, Managing Director of Kody Technolab Limited, stated that the Agreement marks a defining moment in their journey to take the healthcare robotics platform to a global scale. He noted that the integrated route established through exclusive manufacturing, global distribution, and on-ground deployment offers a powerful path to international markets.
Prashant Sawant, Chairman & MD of Sccore AI Tech Diagnostic Limited, added that the Medigo range provides a uniquely scalable platform for clinical-grade screening, multilingual interaction, and real-time data delivery, enabling them to meet the critical need for timely, affordable preventive screening globally.
KODYTECH Stock Price Movement
Shares of Kody Technolab Limited rallied today in the post-market session, closing at ₹1122.05 after posting a solid 0.43% gain. The equity reached its 52-week maximum of ₹1160 during trading, with total volume reaching 64,700 shares recorded by the end of the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: